Independent report
Evaluation of Myanmar Artemisinin Monotherapy Replacement Malaria Project
Myanmar Artemisinin Monotherapy Replacement Malaria Project (AMTR) Independent Evaluation
Documents
Details
This report presents the summary of findings and final assessment of an independent, external evaluation of the DFID co-funded project “Replacement of malaria monotherapy drugs in the private sector to support the containment of drug resistant malaria in eastern Burma” or, in short, the “artemisinin monotherapy replacement” project (AMTR). The AMTR project was launched in 2012 while the evaluation project started with some delay in 2013.
Updates to this page
Published 15 May 2018